Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

NCT00417833 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Diabetic Proliferative Retinopathy
Vascular Vein Oclussion
Choroidal Neovascularization

Interventions

DRUG: Intravitreal Bevacizumab

Sponsor

Asociación para Evitar la Ceguera en México